Cite
HARVARD Citation
Keywood, C. et al. (2009). A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease. Gut. 58 (9), pp. 1192-1199. [Online].